J.P. Morgan Day 1: Companies Make Deal-Making, COVID-19 Promises
Updates From Amgen, Gilead, Alnylam, Vertex, BioNTech, BioMarin, Merck KGAA
Daily round-up from the virtual J.P. Morgan Healthcare Conference: Business development is key topic for Amgen and Vertex; BioNTech talks COVID-19 vaccine supply while Merck KGAA's new CEO pledges to rise to meet the challenges posed by COVID-19.
